MECOM and acute myeloid leukemia: While the reliance of EVI1 on interaction with other transcriptionally active proteins, e.g. CtBP1 [5], has been recognised and provides potential angles for therapeutic approaches, spatiotemporal dynamics of the EVI1 protein isoforms in AML are incompletely understood, but would be important for the development of EVI1-targeted therapeutic approaches.